Revenue (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Year Ended December 31,
	2022		2021
Patient services
Capitated revenue	$	61,341	$	54,285
FFS revenue	105,444		69,789
Subtotal	166,785		124,074
Dispensary revenue	79,343		72,550
Clinical research trials and other revenue	6,355		6,379
Total	$	252,483	$	203,003